Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
24,189,141
-
Total 13F shares
-
606,234
-
Share change
-
+603,331
-
Total reported value
-
$2,424,129
-
Put/Call ratio
-
42%
-
Price per share
-
$4.00
-
Number of holders
-
29
-
Value change
-
+$2,412,517
-
Number of buys
-
25
Institutional Holders of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) as of Q4 2024
As of 31 Dec 2024,
Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
606,234 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Squarepoint Ops LLC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, STATE STREET CORP, Fisher Asset Management, LLC, NORTHERN TRUST CORP, and Arkadios Wealth Advisors.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.